These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37827953)

  • 1. Assessing the cardiovascular events and clinical outcomes of COVID-19 on patients with primary aldosteronism.
    Wu VC; Chen JY; Lin YH; Wang CY; Lai CC
    J Microbiol Immunol Infect; 2023 Dec; 56(6):1158-1168. PubMed ID: 37827953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of dementia in primary aldosteronism compared with essential hypertension: a nationwide cohort study.
    Hong N; Kim KJ; Yu MH; Jeong SH; Lee S; Lim JS; Rhee Y
    Alzheimers Res Ther; 2023 Aug; 15(1):136. PubMed ID: 37568223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary aldosteronism and essential hypertension: assessment of cardiovascular risk at diagnosis and after treatment.
    Turchi F; Ronconi V; di Tizio V; Ceccoli L; Boscaro M; Giacchetti G
    Nutr Metab Cardiovasc Dis; 2014 May; 24(5):476-82. PubMed ID: 24630976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of SARS-CoV-2 Infection With Psychological Distress, Psychotropic Prescribing, Fatigue, and Sleep Problems Among UK Primary Care Patients.
    Abel KM; Carr MJ; Ashcroft DM; Chalder T; Chew-Graham CA; Hope H; Kapur N; McManus S; Steeg S; Webb RT; Pierce M
    JAMA Netw Open; 2021 Nov; 4(11):e2134803. PubMed ID: 34783824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection.
    Ioannou GN; Locke E; Green P; Berry K; O'Hare AM; Shah JA; Crothers K; Eastment MC; Dominitz JA; Fan VS
    JAMA Netw Open; 2020 Sep; 3(9):e2022310. PubMed ID: 32965502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term mortality and cardiovascular events in patients with unilateral primary aldosteronism after targeted treatments.
    Wu VC; Wang SM; Huang KH; Tsai YC; Chan CK; Yang SY; Lin LY; Chang CC; Lu CC; Lin YH; Chen YM; Chueh JS
    Eur J Endocrinol; 2021 Dec; 186(2):195-205. PubMed ID: 34851859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Plasma Concentrations of ACE2 in Primary Aldosteronism and Cardiovascular Outcomes.
    Wu VC; Peng KY; Hu YH; Chang CC; Chan CK; Lai TS; Lin YH; Wang SM; Lu CC; Liu YC; Tsai YC; Chueh JS
    J Clin Endocrinol Metab; 2022 Nov; 107(12):3242-3251. PubMed ID: 36125178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Aldosteronism in Patients in China With Recently Detected Hypertension.
    Xu Z; Yang J; Hu J; Song Y; He W; Luo T; Cheng Q; Ma L; Luo R; Fuller PJ; Cai J; Li Q; Yang S;
    J Am Coll Cardiol; 2020 Apr; 75(16):1913-1922. PubMed ID: 32327102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of sepsis in patients with primary aldosteronism.
    Chan CK; Hu YH; Chen L; Chang CC; Lin YF; Lai TS; Huang KH; Lin YH; Wu VC; Wu KD;
    Crit Care; 2018 Nov; 22(1):313. PubMed ID: 30463626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Higher risk of chronic kidney disease and progressive kidney function impairment in primary aldosteronism than in essential hypertension. Case-control study.
    Fernández-Argüeso M; Pascual-Corrales E; Bengoa Rojano N; García Cano A; Jiménez Mendiguchía L; Araujo-Castro M
    Endocrine; 2021 Aug; 73(2):439-446. PubMed ID: 33797699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of primary and secondary hyperparathyroidism and its cardiometabolic implications in primary aldosteronism.
    Araujo-Castro M; Pascual-Corrales E; Fernández-Argüeso M; Bengoa-Rojano N; García Cano A; Jiménez Mendiguchía L; Cuesta M
    Minerva Endocrinol (Torino); 2023 Dec; 48(4):401-410. PubMed ID: 37166400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative SARS-CoV-2 infection increases risk of early postoperative cardiovascular complications following noncardiac surgery.
    SenthilKumar G; Verhagen NB; Sheriff SA; Yang X; Figueroa Castro CE; Szabo A; Taylor BW; Wainaina N; Lauer K; Gould JC; Kothari AN;
    Am J Physiol Heart Circ Physiol; 2023 Jun; 324(6):H721-H731. PubMed ID: 36930659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Metabolic Syndrome With Long-Term Cardiovascular Risks and All-Cause Mortality in Elderly Patients With Obstructive Sleep Apnea.
    Liu L; Su X; Zhao Z; Han J; Li J; Xu W; He Z; Gao Y; Chen K; Zhao L; Gao Y; Wang H; Guo J; Lin J; Li T; Fang X
    Front Cardiovasc Med; 2021; 8():813280. PubMed ID: 35198606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform.
    Bhaskaran K; Rentsch CT; Hickman G; Hulme WJ; Schultze A; Curtis HJ; Wing K; Warren-Gash C; Tomlinson L; Bates CJ; Mathur R; MacKenna B; Mahalingasivam V; Wong A; Walker AJ; Morton CE; Grint D; Mehrkar A; Eggo RM; Inglesby P; Douglas IJ; McDonald HI; Cockburn J; Williamson EJ; Evans D; Parry J; Hester F; Harper S; Evans SJ; Bacon S; Smeeth L; Goldacre B
    PLoS Med; 2022 Jan; 19(1):e1003871. PubMed ID: 35077449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risky business: a single-centre cross-sectional analysis of calculated cardiovascular risk in patients with primary aldosteronism and essential hypertension.
    Solanki P; Gwini SM; Libianto R; Gabb G; Shen J; Young MJ; Fuller PJ; Yang J
    BMJ Open; 2022 Nov; 12(11):e062406. PubMed ID: 36375972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
    Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Who should be screened for primary aldosteronism? A comprehensive review of current evidence.
    Huang WC; Lin YH; Wu VC; Chen CH; Siddique S; Chia YC; Tay JC; Sogunuru G; Cheng HM; Kario K
    J Clin Hypertens (Greenwich); 2022 Sep; 24(9):1194-1203. PubMed ID: 36196469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of primary aldosteronism in newly diagnosed diabetes mellitus with hypertensive patients.
    Hu Y; Liu W; Zhang J; Su X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 45(8):923-928. PubMed ID: 33053533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.